Cite
Dampalla CS, Rathnayake AD, Perera KD, et al. Structure-Guided Design of Potent Inhibitors of SARS-CoV-2 3CL Protease: Structural, Biochemical, and Cell-Based Studies. J Med Chem. 2021;doi: 10.1021/acs.jmedchem.1c01037.
Dampalla, C. S., Rathnayake, A. D., Perera, K. D., Jesri, A. M., Nguyen, H. N., Miller, M. J., Thurman, H. A., Zheng, J., Kashipathy, M. M., Battaile, K. P., Lovell, S., Perlman, S., Kim, Y., Groutas, W. C., & Chang, K. O. (2021). Structure-Guided Design of Potent Inhibitors of SARS-CoV-2 3CL Protease: Structural, Biochemical, and Cell-Based Studies. Journal of medicinal chemistry, . https://doi.org/10.1021/acs.jmedchem.1c01037
Dampalla, Chamandi S, et al. "Structure-Guided Design of Potent Inhibitors of SARS-CoV-2 3CL Protease: Structural, Biochemical, and Cell-Based Studies." Journal of medicinal chemistry vol. (2021). doi: https://doi.org/10.1021/acs.jmedchem.1c01037
Dampalla CS, Rathnayake AD, Perera KD, Jesri AM, Nguyen HN, Miller MJ, Thurman HA, Zheng J, Kashipathy MM, Battaile KP, Lovell S, Perlman S, Kim Y, Groutas WC, Chang KO. Structure-Guided Design of Potent Inhibitors of SARS-CoV-2 3CL Protease: Structural, Biochemical, and Cell-Based Studies. J Med Chem. 2021 Dec 05; doi: 10.1021/acs.jmedchem.1c01037. Epub 2021 Dec 05. PMID: 34865476; PMCID: PMC8673480.
Copy
Download .nbib